The criterion of triple negative (ER/PR/Her2) breast cancer diagnosed in a woman younger than 60 years of age was met by 4.9% of female cases overall, and at a higher proportion (10.0%) in black or African American cases. The gene discussed is ESR1; the disease is breast cancer.